TAURINE IN THE COMPLEX TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION


S.A. Abduragimov (1), N.V. Teplovа (1), N.A. Volov (1), S.L. Sofrina (2), M.A. Benevskaya (1)

(1) FSBEI HE RNSMU n.a. N.I. Pirogov of RMH, Moscow; (2) CCH № 15 n.a. O.M. Filatov, Moscow
Inclusion of taurine in a daily dose of 750 mg in the standard therapy in patients with chronic heart failure with preserved ejection fraction improves exercise tolerance, improves the functional class of heart failure and reduces the number of re-admissions due to decompensation. The use of this drug improves diastolic left ventricular function without significant dynamics in the size of the left heart chambers and ejection fraction. The efficacy of taurine in the treatment of patients is confirmed by significant decrease in blood NT-proBNP and galectin 3 levels.

About the Autors


Corresponding author: S.A. Abduragimov – postgraduate student at the Department of Hospital Therapy № 1 of the Medical Faculty FSBEI HE RNSMU n.a. N.I. Pirogov of RMH, Moscow; e-mail: sultan_133@mail.ru


Similar Articles


Бионика Медиа